I would like to welcome visitors to Philadelphia and remind them that we are in the midst of celebrating our 300th birthday and looking forward to our fourth century as a thriving city. For the past year the city has undertaken an orgy of reminiscences and the commemoration of historic events. Philadelphia is gifted in preserving and recalling its past, and we would like to think that we are also interested in the development of an exciting future. All this historical reminiscing may provide an adequate excuse to look back at the work that we have done at the Institute for Cancer Research over the past 18 years which led to the discovery of the hepatitis B virus, the invention of the vaccine to protect against it, the possibility of prevention of primary cancer of the liver, and the many developments in our knowledge of this interesting virus. I hope that our extended discussion of the past won’t detract from an interest in our current work, to which I will also refer briefly.
KeywordsPrimary Liver Cancer Keynote Address Primary Hepatocellular Carcinoma Chronic Carrier Australia Antigen
Unable to display preview. Download preview PDF.
- 10.Blumberg, B. S. and Millman, I. Vaccine against viral hepatitis and process. Serial No. 864,788 filed 10/8/69, Patent 36 36 191 issued 1/18/72, U.S. Patent Office.Google Scholar
- 13.Blumberg, B. S., London, W. T., and Sutnick, A. I. (1969). Relation of Australia antigen to virus of hepatitis. Bull. of Path. 10:164.Google Scholar
- 25.London, W. T., Stevens, R. G., Shofer, F. S., Drew, J. S., Brunhofer, J. E., and Blumberg, B. S. (1982). Effects of hepatitis B virus on the mortality, fertility, and sex ratio of human populations, in Viral Hepatitis, 1981 International Symposium, W. Szmuness, H. J. Alter and J. E. Maynard, eds., Franklin Institute Press, Philadelphia, pp. 195–202.Google Scholar
- 32.London, W. T. and Blumberg, B. S. (1982). Hepatitis B and related viruses in chronic hepatitis, cirrhosis and hepatocellular carcinoma in man and animals, in Chronic Active Liver Disease, S. Cohen and R. D. Soloway, eds., Churchill Livingstone, New York, pp. 147–170.Google Scholar
- 33.Blumberg, B. S., and London, W. T. (1983). Hepatitis B virus pathogenesis and prevention of primary cancer of the liver, in Accomplishments in Cancer Research 1981, General Motors Cancer Research Foundation, J. G. Fortner and J. E. Rhoads, eds., J. B. Lippincott Company, Philadelphia, pp. 184–201.Google Scholar
- 36.Nayak, N. C., Dhark, A., Sachdeva, R., Mittal, A., Seth, H. N., Sudarsanam, D., Reddy, B., Wagholikar, U. L., and Reddy, C. R. R. M. (1977). Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int. J. Cancer 20:643.PubMedCrossRefGoogle Scholar
- 40.Larouze, B., London, W. T., Saimot, G., Werner, B. G., Lustbader, E. D., Payet, M., and Blumberg, B. S. (1976). Host responses to hepatitis B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet 2:534–538.Google Scholar
- 43.London, W. T. Observations on hepatoma, in Viral Hepatitis, G. N. Vyas, S. N. Cohen and R. Schmid, eds., Franklin Institute Press, Philadelphia, pp.455-458.Google Scholar
- 44.Macnab, G. M., Alexander, J. J., Lecatsas, G., Bey, E. M.,. and Urbanowicz, J. M. Hepatitis B surface antigen produced by a human hepatoma cell line. Br. J. Cancer 34:509.Google Scholar
- 46.Marion, P. L. and Robinson, W. S. (1980). Hepatitis B virus and hepatocellular carcinoma, in Viruses in Naturally Occurring Cancers, M. Essex, G. Todaro and H. zur Hausen, eds., Cold Spring Harbor Conferences on Cell Proliferation, Vol. 7, Cold Spring Harbor: Cold Spring Harbor Laboratory, pp. 423.Google Scholar
- 47.Gray, P., Edman, J. C., Valenzuela, P., Goodman, H. M., and Rutter, W. J. (1980). A human hepatoma cell line contains hepatitis B DNA and RNA sequences. J. Supramolec. Struc. (Suppl). 4:245.Google Scholar